Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea 2023-02-09 09:21
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Based on ReviR's Comprehensive Approach to RNA-targeted Technologies 2023-02-08 22:00
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center 2023-02-08 20:00
Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc. 2023-02-08 16:05
Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting 2023-02-07 22:00
RNAimmune mRNA Cancer Vaccine Program Accepted for Oral Presentation at the 2023 AACR Annual Meeting 2023-02-07 16:34
J INTS BIO, Oral TKI 'JIN-A04', poster presentation of HER2 exon20 insertion mutation in NSCLC 2023-02-07 12:23
Thermo Fisher Scientific launches Cell Therapy Collaboration Center Program in Singapore to accelerate therapy development across Asia Pacific 2023-02-07 11:00
Tavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis 2023-02-07 06:00
Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment 2023-02-06 21:10
Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb 2023-02-06 18:00
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients 2023-02-06 13:01
Boehringer Ingelheim Philippines is awarded Top Employer for the 5th year in a row 2023-02-06 08:00
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer 2023-02-03 22:00
Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase 1b/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Relapsed/Refractory Multiple Myeloma 2023-02-03 20:30
Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent 2023-02-03 14:34
BriSTAR Immunotech to Present at the BIO CEO & Investor Conference 2023-02-02 19:37
TotalEnergies ENEOS Signs Solar Rooftop Project with Ecolite, a health and wellness company in Malaysia 2023-02-02 10:00
Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan) 2023-02-02 05:00
CN Energy Group. Inc. Announces Closing of $10 Million Underwritten Public Offering 2023-02-01 22:59
1 89.5 90.5 91.5 92.5 93.5 415